Latest Nanomedicine Stories
New groundbreaking research by scientists at Trinity College Dublin has found that exposure to nanoparticles can have a serious impact on health, linking it to rheumatoid arthritis and the development of other serious autoimmune diseases.
In Switzerland, more than 20,000 people (37% of all deaths) die of cardiovascular disease caused by atherosclerosis each year.
A new generation of cancer treatments based on nanotechnology is making its way out of the laboratory and into the clinic with the promise of targeting cancer cells while steering clear of healthy tissue.
Pared-down nucleic acid nanoparticle poses less risk of side effects, offers better targeting.
A whole new class of biosensor that can detect exceptionally small traces of contaminants in liquids in just 40 minutes has been developed by a UNSW-led team of researchers.
A pioneering study to gauge the toxicity of quantum dots in primates has found the tiny crystals to be safe over a one-year period, a hopeful outcome for doctors and scientists seeking new ways to battle diseases like cancer through nanomedicine.
This invention could give new meaning to the term "bad breath!" It's the Single Breath Disease Diagnostics Breathalyzer, and when you blow into it, you get tested for a biomarker—a sign of disease.
Researchers at the Massachusetts Institute of Technology (MIT) and Brigham and Women’s Hospital, a teaching affiliate of Harvard Medical School, recently released information that they have studied a nanoparticle to help the immune system.
Current nanomedicine research has focused on the delivery of established and novel therapeutics.
Engineered nanomaterials, prized for their unique semiconducting properties, are already prevalent in everyday consumer products — from sunscreens, cosmetics and paints to textiles and solar batteries — and economic forecasters are predicting the industry will grow into $1 trillion business in the next few years.